Kali Therapeutics Named to the 2026 Endpoints 11, Recognizing Biotech's Most Promising Startups

SAN MATEO, Calif., Sept. 25, 2026 /PRNewswire/ -- Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, today announced its selection as a winner of the 2026 Endp…

Summary from PR Newswire - Clinical Trials.

Coverage 1 article · 1 outlet

1. PR Newswire - Clinical Trials 1h ago
   Kali Therapeutics Named to the 2026 Endpoints 11, Recognizing Biotech's Most Promising Startups ↗